Описание
Obesity prevalence and its associated comorbidities including metabolic syndrome, cardiovascular disease, and cancer provide the clinical context for evaluating resveratrol's therapeutic potential.
Cite This Figure
![Figure 1: Obesity prevalence and its associated comorbidities including metabolic syndrome, cardiovascular disease, and cancer provide the clinical context for evaluating resveratrol's therapeutic potential.]() > Source: Laura M Mongioì et al. "The Role of Resveratrol Administration in Human Obesity.." *International journal of molecular sciences*, 2021. PMID: [33921991](https://pubmed.ncbi.nlm.nih.gov/33921991/)
<figure> <img src="" alt="Obesity prevalence and its associated comorbidities including metabolic syndrome, cardiovascular disease, and cancer provide the clinical context for evaluating resveratrol's therapeutic potential." /> <figcaption>Figure 1. Obesity prevalence and its associated comorbidities including metabolic syndrome, cardiovascular disease, and cancer provide the clinical context for evaluating resveratrol's therapeutic potential.<br> Source: Laura M Mongioì et al. "The Role of Resveratrol Administration in Human Obesity.." <em>International journal of molecular sciences</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33921991/">33921991</a></figcaption> </figure>